CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...
On track to deliver Portfolio Receipts of $4.7 billion or more by 2030, significantly ahead of consensusGoal to achieve at least mid-teens average annual total shareholder return over next 5 years ...
Missense variants in the O-GlcNAc transferase ( OGT) gene have recently been shown to segregate with a syndromic form of intellectual disability (OGT-ID), underscoring the importance of protein ...
Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and ...
Geopolitics, private equity, and the emergence of the crypto sector and stablecoins pose potential systemic risks, central bankers and academic experts have warned. Panellists at the European Systemic ...
15x AMA Champion Ricky Carmichael and 9x AMA Champion Ryan Villopoto recap the week in Pro Motocross and Supercross. A Division of NBCUniversal. DISCLAIMER: This site and the products offered are for ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Toby Walters is a financial writer, investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback